Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 251 entries
View as:

Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)

Phase: N/A Priority: Normal
NCT ID: NCT01360866 Org: User:
Start: 10/31/11 End: 05/18/17 Due: 05/18/18

A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01299454 Org: User:
Start: 12/31/10 End: 07/31/11 Due: 07/31/12

Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01727700 Org: User:
Start: 11/30/12 End: 09/30/13 Due: 09/30/14

Broad Effectiveness: Study With Aripiprazole

Phase: N/A Priority: Normal
NCT ID: NCT00036361 Org: User:
Start: 07/31/02 End: 01/31/03 Due: 01/31/04

Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02012218 Org: User:
Start: 11/30/13 End: 10/31/14 Due: 10/31/15

Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Phase: N/A Priority: Normal
NCT ID: NCT02964273 Org: User:
Start: 09/23/16 End: 11/17/21 Due: 11/17/22

Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04830215 Org: User:
Start: 04/01/21 End: 05/27/22 Due: 05/27/23

A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT05279313 Org: User:
Start: 02/24/22 End: 03/25/26 Due: 03/25/27

A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05593029 Org: User:
Start: 11/09/22 End: 02/28/26 Due: 02/28/27

PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01854944 Org: User:
Start: 09/30/13 End: 08/31/14 Due: 08/31/15

Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03872596 Org: User:
Start: 03/27/19 End: 11/27/19 Due: 11/27/20

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00797966 Org: User:
Start: 05/31/09 End: 07/31/10 Due: 07/31/11

A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05463770 Org: User:
Start: 08/30/22 End: 08/22/23 Due: 08/22/24

A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)

Phase: N/A Priority: Normal
NCT ID: NCT03033069 Org: User:
Start: 01/26/17 End: 11/12/18 Due: 11/12/19

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT02446132 Org: User:
Start: 12/31/15 End: 09/06/24 Due: 09/06/25

Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety

Phase: N/A Priority: Normal
NCT ID: NCT05504486 Org: User:
Start: 08/29/22 End: 04/05/23 Due: 04/05/24

Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01397786 Org: User:
Start: 09/30/11 End: 01/31/16 Due: 01/31/17

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05113953 Org: User:
Start: 12/16/21 End: 08/30/22 Due: 08/30/23

FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00064454 Org: User:
Start: 05/31/03 End: 07/31/06 Due: 07/31/07

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01670279 Org: User:
Start: 07/31/12 End: 05/31/13 Due: 05/31/14

A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's

Phase: N/A Priority: Normal
NCT ID: NCT06928142 Org: User:
Start: 04/15/25 End: 06/04/27 Due: 06/04/28

The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03324581 Org: User:
Start: 11/09/17 End: 10/31/18 Due: 10/31/19

Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT01438060 Org: User:
Start: 08/31/00 End: 07/31/10 Due: 07/31/11

Aripiprazole Open-Label, Safety and Tolerability Study

Phase: N/A Priority: Normal
NCT ID: NCT00102518 Org: User:
Start: 09/30/04 End: 02/28/07 Due: 02/28/08

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00731549 Org: User:
Start: 12/31/08 End: 11/30/13 Due: 11/30/14